Aripiprazol vs risperidona en el tratamiento a corto plazo de primeros episodios psicóticos no afectivos: ensayo clínico aleatorizado, de 12 semanas, abierto, dosis flexible.
Bibliografía
1. Crespo-Facorro, B., Pelayo-Teran, J.M. and Mayoral-Van Son J.. Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther. 2016; 5(2): 105-130.
2. Robinson, D.G., Woerner, M.G., Delman, H.M. and Kane, J.M.. Pharmacological Treatments for First-Episode Schizophrenia. Schizophr Bull. 2005; 31(3): 705–722.
3. Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013; 382(9896): 951-962.
4. Huhn, M., Nikolakopoulou, A., Scheneider-Thoma, J., Krause, M., Samara, M., Peter, N. et al. Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults with Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis. Lancet. 2019; 394(10202): 939–951.